Elucidating the cell of origin in human cancer is fundamental to understanding its pathogenesis and provides better biomarkers and molecular targets for early detection and effective prevention. Human cancers can be traced back to the neoplastic transformation of ancestral cells, most often somatic stem cells, which are responsible for regeneration of the tissue type in which the cancer arises. The transformed cells evolve into a full-blown and clinically evident tumour through a complex process of clonal expansion and selection, driven by the interplay between molecular genetic alterations in cells and their microenvironmental pressures. While the origins are clear in many human malignant neoplasms, the origin of ovarian high-grade serous carcinoma (HGSC), the most common and aggressive type of ovarian epithelial cancer, remains poorly understood [1] . The fact that very few precursors are detected on the ovarian surface, the advanced stage of the cancer when it presents, and the failure of early detection using imaging and CA-125 have puzzled pathologists, clinicians, and researchers, who struggle to understand why these conundrums occur in ovarian HGSC.
The 'dormant' period in advancing this field has resulted from the dominant paradigm over the last few decades: the presumption that precursors of ovarian carcinoma would logically be located in the ovaries. As a result, the Fallopian tubes were not extensively sampled and examined. In 2001, Piek et al first described dysplastic lesions that morphologically resemble HGSC in the Fallopian tube from a group of patients with a genetic predisposition to ovarian cancer who were undergoing risk-reducing salpingo-oophorectomy [2] . This study opened a new era of ovarian cancer research and invited pathologists to inspect the Fallopian tubes carefully using a protocol entitled 'sectioning and extensively examining the fimbriated end' (SEE-FIM) [3] . The introduction of this new pathology practice not only confirmed the original report but also identified a series of tubal lesions in women with average and increased risk of developing ovarian cancer [4] . The junction between STIC and HGSC is indicated by an asterisk. The image was reconstructed from a series of consecutive sections stained with a p53 antibody using the Voloom program (microDimensions, Munich, Germany). This lesion has a TP53 missense mutation, which is reflected in the intense brown nuclear staining. It can be appreciated that the STIC, which is a monolayer covering the fimbrial surface, becomes focally invasive into the underlying stroma, where it connects to the HGSC. The figure can be fully visualized in 360 ∘ at http://www.gynecologycancer.org/new-page-2/.
The tubal lesions span a spectrum of morphologically and immunohistochemically related lesions, including serous tubal intraepithelial carcinoma (STIC), serous tubal intraepithelial lesion (STIL), and p53 signatures [5] [6] [7] . STIC is not uncommonly associated with HGSC, and occasionally the transition from STIC to HGSC can be appreciated histologically ( Figure 1 ). These findings and the availability of tissues containing these lesions inspired researchers to perform molecular genetic and cell biology-based studies to reveal the molecular features of the presumed precursor, STIC, and of HGSC [4] . Sequencing analysis reveals identical TP53 mutations in both STIC and associated HGSC from the same patients in most cases [4, 8] . STICs and occult invasive tubal carcinomas occur not only in 2-5% of women with a germline BRCA1 or BRCA2 mutation but also in approximately half of women with sporadic ovarian cancer; however, they rarely appear in women with other gynaecological malignancies and disorders [9, 10] . The gene expression signature of HGSC is more closely related to Fallopian tube epithelium than to ovarian surface, endometrial, or colonic epithelium [11] . In addition, STICs, but not the adjacent normal tubal epithelium, express several HGSC-associated tumour-promoting proteins, including fatty acid synthase, Rsf-1, and cyclin E1 [12] . Furthermore, two genetically engineered mouse models that use Müllerian-specific promoters (PAX8 and ovarian glycoprotein-1, respectively) to express oncoproteins spontaneously manifest lesions resembling human STICs and tubal carcinomas [13, 14] . The carcinoma invades into the adjacent ovarian tissue, forming 'ovarian' carcinomas. While the above findings only suggest that STIC and HGSC are clonally and molecularly related, further studies using telomere fluorescence in situ hybridization (FISH) and CCNE1 FISH together with centrosome number counting demonstrated that STICs, compared with their concurrent HGSCs, contain less molecular abnormality, supporting the notion that STICs may be a precursor of many HGSCs [15, 16] .
Based on these studies, it would be logical to surmise that many ovarian HGSCs develop from STIC and/or occult tubal carcinoma that then exports to the ovary. In this biological scenario, it would be critical to understand how tubal epithelium is transformed because this new knowledge would help future endeavours to develop better prevention strategies for ovarian cancer. In fact, epidemiological studies have offered some clues. It is well established that women with inherited germline mutations in genes responsible for the DNA damage repair pathways, most notably BRCA1 and BRCA2, have a genetic predisposition to ovarian HGSC. Moreover, the risk of ovarian HGSC is known to be associated with the accumulated number of ovulations, and it has been shown that ovulatory follicular fluid flushes onto epithelial cells on the fimbrial surface. This causes DNA strand breaks by the DNA-insulting molecules, including reactive oxygen species (ROS), in the follicular fluid. This fluid then comes to reside in a cul-de-sac as peritoneal fluid. To harness DNA damage and protect cells from death or carcinogenesis, Fallopian tubes and their microenvironments must have developed mechanisms to counteract oxidative stress. Towards this end, the research article published in a recent issue of this journal [17] provides new insight.
The research team from Taiwan reported that ferryl haemoglobin (Hb) in peritoneal fluid could prevent cell death from ROS-stressed and DNA-damaged fimbrial epithelial cells, and they suggested that peritoneal blood may facilitate ovulation-induced carcinogenesis of tubal epithelium [17] . This study springs from the authors' previous intriguing observation that despite the occurrence of lethal DNA double-strand breaks after exposure to high ROS-containing ovulatory follicular fluid, some Tubal origin of ovarian cancer 5 of the tubal epithelial cells survived in these harsh conditions, raising the possibility of protective effects of ROS-induced cytotoxicity [18] . Using mass spectrometry and peptide sequencing, they identified ferryl Hb β-chain in the peritoneal fluid as the major factor that rescued tubal epithelial cells from ROS-induced cell death. Though it may appear counter-intuitive, blood can serve as a double-edged sword from the perspective of the tubal epithelium. The ferrous iron in blood catalyses Fenton's reaction, the ROS product of which damages DNA. On the other hand, Hb from the blood protects cells from ROS-induced cell death. The authors' finding is thus of potential interest in considering the very early molecular events leading to cellular transformation. Repeated DNA damage can be mutagenic, but normal cells evolve a highly effective cancer-protecting mechanism by simply deleting those heavily DNA-damaged and presumably mutated cells (exceeding the repair capacity) through apoptosis. In addition to the rescue effect of Hb, like HGSCs, tubal lesions including STICS and STILS have defective p53 due to missense or nonsense mutations. Lack of normal p53 function inactivates p53-mediated cell apoptosis in response to DNA damage, further encouraging tubal epithelium to survive. It can also be argued that defects in DNA damage repair pathways such as those involving BRCA1 or BRCA2 would further promote mutagenesis. The surviving cells harbouring somatic mutations in cancer driver genes fuel tumour evolution after they clonally expand to establish cancer precursors, such as STICs. It should be noted that blood is always present in follicular and peritoneal fluid, as it comes from multiple sources, including menstrual blood and ovulation-associated tissue disruption from vascular-enriched granulosa layers. Thus, the double-edged sword of Hb threatens women with the possibility of a highly unwelcome outcome: the promotion of tumour initiation in the Fallopian tube epithelium.
There are several questions waiting to be addressed before this conclusion can become cogent or new research directions can be created. First, it is uncertain if the follicular fluid collected during follicle induction during assisted oocyte retrieval and used in this study is chemically and biologically similar to ovulatory follicular fluid without induction. Second, why some tubal epithelial cells are sensitive to ROS-induced cytotoxicity while others are refractory still needs to be investigated. Third, the finding from this study should have implications in studying endometriosis, especially ovarian endometriotic cysts that may develop into ovarian clear cell and endometrioid carcinoma. Finally, it is important to further investigate the chemical and biological basis underlying how even with its transient nature and short half-life, ferryl Hb can scavenge the extracellular hydrogen peroxide and reduce local oxidative stress in vivo. The advent of the tubal paradigm of the origin of ovarian HGSC is changing many aspects of ovarian cancer research and impacting routine gynaecology practice. The results from this study will likely inspire future studies to uncover the detailed cellular response of tubal epithelial cells to the ovulatory microenvironment. This, in turn, will allow scientists to embark on translational research focusing on developing strategies to prevent ovarian cancer in women at an increased risk of developing the disease.
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